See the markers behind your biological age
150+ biomarkers, run through CLIA-certified labs
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What is a biological age test?
A biological age test estimates how old your cells and tissues appear to be, based on molecular or clinical markers rather than the years since your birth. It reads a sample, usually blood or saliva, and returns an age estimate or an aging rate. It is an estimate of biological aging, framed as a biomarker of ageing, not a diagnostic test.
Aging, at cell and tissue level, is not one process. It is a set of interacting ones, including epigenetic alterations, telomere attrition, chronic inflammation, and cellular senescence, which together make up twelve recognized hallmarks of aging. No single test captures all twelve, which is exactly why different methods disagree with each other.
You will see the same idea sold under several names: epigenetic age test, aging clock, longevity panel, pace-of-aging test. Those labels describe different methods with different evidence behind them, not one standard test.
Biological age vs. chronological age
Chronological age is time elapsed since birth and is identical for everyone born on the same day, while biological age is an estimate of how much aging has actually accumulated, so two people who share a birthday can score years apart. The distinction exists because conventional clinical measures poorly represent the underlying mechanisms of ageing.
The gap between the two numbers is where the meaning sits. At population level, when methylation age runs ahead of chronological age, that acceleration tracks with worse outcomes: a 5-year higher methylation age carried a 21% higher mortality risk adjusted for age and sex, and 16% after further adjustment for IQ, education, social class, hypertension, diabetes, cardiovascular disease, and APOE status. That is a statement about groups of people, not a forecast for any one of them.
How biological age tests work
Biological age tests work by measuring a defined set of markers in a sample, then running those values through an algorithm trained on data from large human cohorts. The output is either an age in years or a rate of aging. Three method families dominate: DNA methylation patterns, telomere length, and routine blood chemistry.
The end-to-end sequence is short and largely the same across providers:
- Choose a method and a provider.
- Prepare according to the provider's instructions.
- Collect the sample: blood draw, dried blood spot, saliva, or cheek swab.
- The lab measures the markers and applies the algorithm.
- Review the result with a clinician alongside the rest of your health data.
One fact governs everything downstream: two tests run on the same person can disagree, because clocks built to predict chronological age and clocks built to predict biological age are distinct constructs with different CpG architecture. They are answering different questions, so they return different answers.
| Method | What it measures | Sample type | What it is good for | Key limitation |
|---|---|---|---|---|
| DNA methylation | Methylation marks at CpG sites | Blood, saliva, cheek swab | Well-validated age estimate | Results vary between clock versions |
| Telomere length | Length of chromosome end-caps | Blood (white cells) | Population-level research | Weak correlation with age |
| Blood biomarker (phenotypic age) | Routine multi-system chemistry | Blood draw | Repeatable, uses standard labs | Reflects current physiology, not DNA |
| Survey-based estimates | Self-reported habits and history | Questionnaire | Free, quick, motivational | No biological measurement at all |
Epigenetic (DNA methylation) clocks
An epigenetic clock reads chemical methylation marks at specific CpG sites on your DNA and converts the pattern into an age estimate. The original multi-tissue clock was built from roughly 8,000 samples across 82 datasets covering 51 healthy tissues and cell types, using 353 CpG sites. Most commercial epigenetic tests are descendants of that design.
Telomere length
Telomeres are the protective caps at the ends of your chromosomes, and telomere-length tests measure how short they have become, usually in white blood cells. The honest limitation is the size of the signal. Pooled correlation between telomere length and chronological age was only −0.19 across 743,019 individuals, weakening further at older ages. Even in the largest characterization to date, age, ethnicity, sex, and white cell count together explained only about 5.5% of the variance in telomere length among 474,074 adults.
Blood biomarker and phenotypic age panels
Phenotypic age panels combine your chronological age with a set of routine clinical chemistry results to produce a biological age estimate, no DNA sequencing involved. The published version uses nine routine multi-system biomarkers plus age, validated in 11,432 US adults aged 20 to 84 with 1,012 deaths over 12.6 years of follow-up. The practical implication is easy to miss: standard bloodwork, not only specialist DNA testing, can generate this estimate, which makes it one of the more repeatable options available to most people.
What the major aging clocks actually measure
The named clocks are not interchangeable. First-generation clocks were trained to predict chronological age, while later ones were trained on composite clinical measures rather than chronological age, or directly on mortality. Each one estimates a different thing, which is why a single "biological age" label across products is misleading.
| Clock | What it estimates | Typical use |
|---|---|---|
| Horvath | Chronological age across many tissues | Baseline multi-tissue age estimate |
| PhenoAge | Age trained on clinical measures | Mortality, healthspan, physical functioning |
| GrimAge | Mortality-trained composite score | Time-to-death, heart disease, cancer |
| DunedinPACE | Rate of aging per year | Tracking change over time |
The distinction most readers miss is DunedinPACE. It does not report an age at all; it reports a pace, meaning how fast you are aging per calendar year, modelled on within-person decline across 19 organ-system indicators measured at four time points over two decades in a single birth cohort. Read it as a speedometer, not an odometer. GrimAge sits at the other end of the design spectrum, built as a composite of seven plasma-protein surrogates plus a methylation estimate of smoking pack-years.
What a biological age test measures in your body
What the test actually reads depends on the method: methylation marks on DNA, the length of your chromosome end-caps, or the concentrations of routine blood markers. Each is a partial proxy for the biology of aging rather than a direct measurement of it, because aging runs as many interacting processes at once.
Methylation is the dominant commercial signal, so it is worth picturing. Over decades, small chemical tags settle onto and shift away from defined positions on your DNA, and they do it in a pattern regular enough that one predictor can be applied across most tissue types. Imagine a strand of DNA gaining and losing those tags at fixed addresses year after year: the clock is simply reading the addresses and doing arithmetic.
The blood side of the story is less exotic and more accessible. Routine multi-system chemistry, the kind of markers a standard panel already draws, tracks mortality risk well enough to underpin a validated biological age measure across a diverse adult population. Your liver enzymes, glucose control, kidney function, and inflammation markers carry more aging signal than most people assume.
How accurate are biological age tests?
Biological age tests are reasonably good at predicting outcomes across large populations and considerably weaker as a precise readout for one person. Biological age testing is not part of standard clinical care, does not diagnose disease, and does not predict an individual's lifespan.
The number that matters most here is a reliability number, not an accuracy number. Technical noise alone produced deviations of up to 9 years between replicate samples across six prominent epigenetic clocks, and principal-component versions of those clocks brought most replicates within about 1.5 years. So a single result is a snapshot with error bars around it, and the width of those bars depends on which version of which clock your provider runs.
What the research supports
The pooled evidence is more persuasive than any single study. Across 23 studies and 41,607 participants, each 5-year increase in DNA methylation age was associated with an 8-15% increased mortality risk.
That finding does not rest on one meta-analysis either. A separate multi-cohort analysis confirmed that methylation-based age predicts all-cause mortality, with prediction improving once blood cell composition is accounted for.
Where the evidence is unsettled
The counterweight comes from the same systematic review that produced the mortality figure: the association between epigenetic age and specific age-related diseases and longevity was inconclusive, and positive publication bias is likely.
The most expectation-calibrating result comes from a nationally representative panel of older US adults. PhenoAge, GrimAge, and DunedinPACE acceleration each predicted cognitive dysfunction, functional limitations, chronic conditions, and 4-year mortality, yet demographics, socioeconomic status, mental health, and health behaviours remained equally or more robust predictors. A clock adds information. It does not replace the basics.
How to take a biological age test
Taking a biological age test means selecting a method, following the provider's collection instructions, submitting a blood or saliva sample, and reviewing the report with a clinician who can set it next to the rest of your health data. The report on its own is a number without context.
A few things are worth knowing before you commit to a method:
- Results are not diagnostic and are not standard clinical care.
- Different tests can return different ages for the same person, because chronological-age and biological-age clocks are built on different CpG architecture.
- Replicate samples can differ by up to 9 years from technical noise alone.
- Telomere-only tests carry the weakest stand-alone evidence, giving only a rough estimate of aging rate.
Blood, saliva, and at-home vs. clinic collection
Sample type changes the answer, so blood and saliva results are not interchangeable. Across 284 samples from 83 people aged 9 to 70 spanning buccal, saliva, dried blood spot, buffy coat, and PBMC tissue, within-person differences between oral- and blood-based estimates averaged almost 30 years for some clocks.
Agreement improves for newer measures but never reaches within-tissue reliability: applying blood-derived algorithms to saliva showed only moderate cross-tissue agreement for second- and third-generation measures and poor agreement for first-generation age-acceleration measures. The rule that follows is simple. Compare like with like, same sample type and same provider, whenever you retest.
How to prepare before testing
Most of what makes a result comparable is under your control, and consistency matters more than any single precaution, given that replicate samples of the same specimen can differ by several years. Before collection:
- Follow the provider's fasting instructions exactly.
- Collect at a consistent time of day.
- Avoid collecting during an acute illness.
- Keep the collection method and provider identical across retests.
What it costs
Pricing varies by provider, method, and country, and these tests are typically paid out of pocket rather than covered as routine care. The main cost driver is the technology: sequencing-based epigenetic tests are the expensive end, because each sample requires a methylation array or sequencing run. Panels built on routine clinical chemistry sit at the cheaper end, since they reuse markers a standard blood panel already measures.
Test 150+ biomarkers
Two blood draws. A full picture of your health, explained in plain language.
Test 150+ biomarkers
Two blood draws. A full picture of your health, explained in plain language.
How to read your biological age results
A biological age result is read as a comparison against your chronological age and, for pace-type tests, as a rate. In every case it describes a population-level risk association, not a personal forecast.
| Result pattern | What it suggests | What it does not mean |
|---|---|---|
| Biological age below chronological age | Favorable profile for your age group | Not proof of a longer life |
| Roughly equal | Typical for your age group | Not a clean bill of health |
| Biological age above chronological age | Associated with higher mortality risk | Not a diagnosis or prediction |
| Pace above 1.0 per year | Aging faster than one year per year | Not a fixed or permanent rate |
Read that number next to your standard clinical measures and health history rather than instead of them, since health behaviours and socioeconomic factors remained equally or more robust predictors of aging-related outcomes than clock acceleration. The context is what makes the number usable.
What can change your biological age
Some interventions have moved biological age measures in randomized trials. The effects are modest, and the evidence is strongest for diet and physical activity. Every finding here is a trial-level average or an observational association, never a personal guarantee.
- Strong: In a randomized controlled trial, 220 adults without obesity assigned to 25% caloric restriction or an ad libitum diet for two years showed a slowed pace of aging on DunedinPACE, with no significant change on PhenoAge or GrimAge and treatment effect sizes described as small.
- Moderate: In a 24-month randomized factorial trial in 219 healthy postmenopausal women, the dietary arm showed significant slowing of the GrimAge clock, while the physical-activity arm instead reduced stochastic epigenetic mutations.
- Moderate: In an 18-month randomized trial in 256 adults with abdominal obesity or dyslipidemia, higher polyphenol intake was inversely associated with biological aging.
- Emerging: An 8-week pilot randomized trial in 43 men aged 50 to 72, combining diet, sleep, exercise, and relaxation guidance with supplements, reported a 3.23-year lower Horvath methylation age versus controls, with the within-group change only trending. Preliminary, and not evidence that biological age can be turned back.
Physical activity deserves its own paragraph, because the observational signal is consistent and the effect size is smaller than the headlines suggest. Accelerometer-measured activity in 3,567 adults aged 30 to 94 was associated with slower epigenetic ageing across multiple clocks. In 2,435 Framingham adults, walking 1,500 more steps per day or spending 3 fewer hours sedentary was associated with more than 10 months lower GrimAge, attenuating to roughly 1 month after adjusting for blood cell composition. If you want a dose to aim at, use the federal recommendation of 150 to 300 minutes of moderate-intensity aerobic activity per week plus two days of muscle-strengthening activity, rather than a step count inferred from a clock study.
How often to retest
Retesting is only informative over intervals long enough for real change to exceed measurement noise, which for most people means months to a year rather than weeks. The reasoning is mechanical: replicate samples of the same specimen can differ by several years on some clocks, so a short-interval change is more likely to be noise than progress.
Keep the provider, clock version, sample type, and collection conditions identical across time points, since cross-tissue comparisons agree only moderately at best. For a sense of realistic timescales, the intervention trials that detected any change ran from 8 weeks to 2 years.
Who a biological age test is for, and who can skip it
A biological age test suits people who already track their health and want an additional research-grade signal to trend over time. It is reasonable to skip if you have not yet covered the basics of standard bloodwork, blood pressure, sleep, and activity, because demographics, socioeconomic status, mental health, and health behaviours remained equally or more robust predictors of aging-related outcomes.
One boundary is worth stating plainly. These tests are not standard clinical care, they are not diagnostic, and they should not be used to make decisions about symptoms. Persistent symptoms warrant evaluation by a clinician, not a longevity panel.
See what your biological age is built on with a Superpower panel
A biological age number is most useful sitting next to the routine markers that explain it, which is where measurement turns into something you can act on. The Superpower Blood Panel covers 150+ markers, including the metabolic, inflammation, and organ-function markers behind the number, or you can add the Organ Age Panel for system-level aging scores. Start with Superpower and build the baseline first.
Frequently Asked Questions
References
- Horvath S, Raj K (2018). DNA methylation-based biomarkers and the epigenetic clock theory of ageing. *Nature Reviews Genetics*, *19*(6), 371–384. https://doi.org/10.1038/s41576-018-0004-3
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2023). Hallmarks of aging: an expanding universe. *Cell*, *186*(2), 243–278. https://doi.org/10.1016/j.cell.2022.11.001
- Marioni RE, Shah S, McRae AF, et al (2015). DNA methylation age of blood predicts all-cause mortality in later life. *Genome Biology*, *16*(1), 25. https://doi.org/10.1186/s13059-015-0584-6
- Bernabeu E, McCartney DL, Gadd DA, et al (2023). Refining epigenetic prediction of chronological and biological age. *Genome Medicine*, *15*(1), 12. https://doi.org/10.1186/s13073-023-01161-y
- Horvath S (2013). DNA methylation age of human tissues and cell types. *Genome Biology*, *14*(10), R115. https://doi.org/10.1186/gb-2013-14-10-r115
- Ye Q, Apsley AT, Etzel L, et al (2023). Telomere length and chronological age across the human lifespan: a systematic review and meta-analysis of 414 study samples including 743,019 individuals. *Ageing Research Reviews*, *90*, 102031. https://doi.org/10.1016/j.arr.2023.102031
- Codd V, Denniff M, Swinfield C, et al (2022). Measurement and initial characterization of leukocyte telomere length in 474,074 participants in UK Biobank. *Nature Aging*, *2*(2), 170–179. https://doi.org/10.1038/s43587-021-00166-9
- Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M (2018). A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. *PLoS Medicine*, *15*(12), e1002718. https://doi.org/10.1371/journal.pmed.1002718
- Levine ME, Lu AT, Quach A, et al (2018). An epigenetic biomarker of aging for lifespan and healthspan. *Aging*, *10*(4), 573–591. https://doi.org/10.18632/aging.101414
- Belsky DW, Caspi A, Corcoran DL, et al (2022). DunedinPACE, a DNA methylation biomarker of the pace of aging. *eLife*, *11*, e73420. https://doi.org/10.7554/eLife.73420
- Lu AT, Quach A, Wilson JG, et al (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. *Aging*, *11*(2), 303–327. https://doi.org/10.18632/aging.101684
- Higgins-Chen AT, Thrush KL, Wang Y, et al (2022). A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. *Nature Aging*, *2*(7), 644–661. https://doi.org/10.1038/s43587-022-00248-2
- Fransquet PD, Wrigglesworth J, Woods RL, Ernst ME, Ryan J (2019). The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. *Clinical Epigenetics*, *11*(1), 62. https://doi.org/10.1186/s13148-019-0656-7
- Chen BH, Marioni RE, Colicino E, et al (2016). DNA methylation-based measures of biological age: meta-analysis predicting time to death. *Aging*, *8*(9), 1844–1865. https://doi.org/10.18632/aging.101020
- Faul JD, Kim JK, Levine ME, Thyagarajan B, Weir DR, Crimmins EM (2023). Epigenetic-based age acceleration in a representative sample of older Americans: associations with aging-related morbidity and mortality. *Proceedings of the National Academy of Sciences*, *120*(9), e2215840120. https://doi.org/10.1073/pnas.2215840120
- Vaiserman A, Krasnienkov D (2021). Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives. *Frontiers in Genetics*, *11*, 630186. https://doi.org/10.3389/fgene.2020.630186
- Apsley AT, Ye Q, Caspi A, et al (2025). Cross-tissue comparison of epigenetic aging clocks in humans. *Aging Cell*, *24*(4), e14451. https://doi.org/10.1111/acel.14451
- Zarandooz S, Raffington L (2025). Applying blood-derived epigenetic algorithms to saliva: cross-tissue similarity of DNA-methylation indices of aging, physiology, and cognition. *Clinical Epigenetics*, *17*(1), 61. https://doi.org/10.1186/s13148-025-01868-2
- Waziry R, Ryan CP, Corcoran DL, et al (2023). Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. *Nature Aging*, *3*(3), 248–257. https://doi.org/10.1038/s43587-022-00357-y
- Fiorito G, Caini S, Palli D, et al (2021). DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study. *Aging Cell*, *20*(10), e13439. https://doi.org/10.1111/acel.13439
- Yaskolka Meir A, Keller M, Hoffmann A, et al (2023). The effect of polyphenols on DNA methylation-assessed biological age attenuation: the DIRECT PLUS randomized controlled trial. *BMC Medicine*, *21*(1), 364. https://doi.org/10.1186/s12916-023-03067-3
- Fitzgerald KN, Hodges R, Hanes D, et al (2021). Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. *Aging*, *13*(7), 9419–9432. https://doi.org/10.18632/aging.202913
- Fox FAU, Liu D, Breteler MMB, Aziz NA (2023). Physical activity is associated with slower epigenetic ageing — findings from the Rhineland study. *Aging Cell*, *22*(6), e13828. https://doi.org/10.1111/acel.13828
- Spartano NL, Wang R, Yang Q, et al (2023). Association of accelerometer-measured physical activity and sedentary time with epigenetic markers of aging. *Medicine & Science in Sports & Exercise*, *55*(2), 264–272. https://doi.org/10.1249/MSS.0000000000003041
- US Department of Health and Human Services (2018). *Physical activity guidelines for Americans* (2nd ed.). US Department of Health and Human Services. https://odphp.health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf
Heart & Vascular Health
Metabolic Health
Energy
Liver Health
Kidney
Sex Hormones
Thyroid Health
Nutrients
Immune System
Inflammation